Malvern, PA, United States of America

Jeffrey Luo

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 55(Granted Patents)


Location History:

  • Malvern, PA (US) (2007 - 2010)
  • Radnor, PA (US) (2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Luo

Introduction

Jeffrey Luo is a notable inventor based in Malvern, PA, who has made significant contributions to the field of biotechnology. With a total of three patents to his name, he has focused on developing innovative solutions that have the potential to impact various medical applications.

Latest Patents

Luo's latest patents include groundbreaking work on melanocortin receptor binding mimetibodies. These compositions involve polypeptides that bind to melanocortin receptors, along with polynucleotides encoding these polypeptides. The patents also detail methods for making and using these mimetibodies. Another significant patent involves BMP-7 variant compositions, which include human Bone Morphogenic Protein 7 (hBMP-7) variant peptide chains and nucleic acids encoding these chains. This work outlines methods for creating and utilizing these innovative compositions.

Career Highlights

Throughout his career, Jeffrey Luo has worked with prominent companies in the biotechnology sector, including Centocor, Inc. and Janssen Biotech, Inc. His experience in these organizations has allowed him to develop and refine his expertise in the field.

Collaborations

Luo has collaborated with several professionals in his field, including Mark Hilary Cunningham and Jacqueline Benson. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Jeffrey Luo's work exemplifies the spirit of innovation in biotechnology. His patents and career achievements highlight his commitment to advancing medical science through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…